Portage Biotech Inc. Common Stock
Symbol: PRTG (NASDAQ)
8.83
▲ (0.28%) 0.025
Company Description:
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
Key Stats
- Today's Open: $8.78
- Today's High: $8.88
- Today's Low: $8.19
- Today's Volume: 15.26K
- Yesterday Close: $8.8
- Yesterday High: $9.1568
- Yesterday Low: $8.22
- Yesterday Volume: 38.02K
- Last Min Volume: 100
- Last Min High: $8.825
- Last Min Low: $8.825
- Last Min VWAP: $8.825
Company Profile
- Name: Portage Biotech Inc. Common Stock
- Website: https://www.portagebiotech.com
- Listed Date: 2021-02-25
- Location: ,
- Market Status: Active
- CIK Number: 0001095435
- SIC Code:
- SIC description:
- Market Cap: $19.78M
- Round Lot: 100
- Outstanding Shares: 2.28M
- Asset Type: CS
RECENT FILINGS FOR PRTG
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-01 | S-8 | View |
| 2025-07-28 | 424B3 | View |
| 2025-07-25 | 424B3 | View |
| 2025-07-25 | 6-K | View |
| 2025-07-25 | 20-F | View |
| 2025-06-27 | 424B3 | View |
| 2025-06-27 | 6-K | View |
| 2025-06-27 | 424B5 | View |
| 2025-06-25 | 424B3 | View |
| 2025-06-25 | 6-K | View |
| 2025-06-09 | 424B3 | View |
| 2025-06-09 | 6-K | View |
| 2025-05-29 | 424B3 | View |
| 2025-05-29 | 6-K | View |
| 2025-05-21 | 424B2 | View |
| 2025-05-14 | EFFECT | View |
| 2025-05-12 | CORRESP | View |
| 2025-05-12 | F-3/A | View |
| 2025-05-12 | CORRESP | View |
| 2025-05-08 | UPLOAD | View |
Latest News on PRTG